SHANGHAI, March 6, 2026 /PRNewswire/ -- Jiahui International Cancer Center (JICC) has stabilized a U.S. patient with advanced non‑small cell lung cancer (NSCLC) and Parkinson's disease using ivonescimab, a novel immunotherapy currently available only in China. The 70‑something patient had...
Hence then, the article about u s patient with advanced lung cancer stabilized by novel immunotherapy treatment in china was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( U.S. Patient with Advanced Lung Cancer Stabilized by Novel Immunotherapy Treatment in China )
Also on site :
- China’s energy fortress was built to withstand just this type of oil shock
- A deadly bacteria is creeping up the Atlantic Coast. How worried should you be?
- From Scrub Daddy to Bombas: The Most Successful 'Shark Tank' Products, Ranked